John Mccartney
VP, Medical Writing
Veterinary Sciences
Karyopharm Therapeutics
United States of America
Biography
John McCartney has joined Karyopharm as VP, Medical Writing to oversee KPT-330 clinical development. John has over 20 years of drug development and project management experience, working previously with GliaMed, EPIX Pharmaceuticals, Point Therapeutics, Cystic Fibrosis Foundation Therapeutics and Curis/Creative BioMolecules.
Research Interest
Veterinary Sciences
